Log In
BCIQ
Print this Print this
 

GSK2251052 (formerly AN3365)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionBoron-based, small-molecule antibiotic targeting the bacterial enzyme leucyl-tRNA synthetase (LARS; LeuRS)
Molecular Target Leucyl-tRNA synthetase (LARS) (LeuRS)
Mechanism of ActionLeucyl-tRNA synthetase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$5,200.0M

$5,200.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/24/2016

$5,200.0M

$5,200.0M

0

Get a free BioCentury trial today